Newly Approved Drug Therapies (218) Acular (ketorolac tromethamine ophthalmic solution) 0.5%, Allergan,

The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Drug Info

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.

Home » Drug Information » FDA-Approved Drugs » 1997
Medical Areas: Ophthalmology

View By: Year Company Therapeutic Areas Drug Names

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Acular (ketorolac tromethamine ophthalmic solution) 0.5%

Company: Allergan
Approval Status: Approved January 1997
Treatment Area: Treatment for postoperative inflammation in patients who have undergone cataract extraction

General Information

Acular has been approved for the treatment of postoperative inflammation in patients who have undergone cataract extraction.

Privacy |
Glossary